Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Neural Anomalies during Vigilance in Schizophrenia: Diagnostic Specificity and Genetic Associations

View ORCID ProfileSamuel D. Klein, Laurie L. Shekels, Kathryn A. McGuire, View ORCID ProfileScott R. Sponheim
doi: https://doi.org/10.1101/2020.04.03.20052100
Samuel D. Klein
1University of Minnesota Clinical Science and Psychopathology Research Program, University of Minnesota-Twin Cities, 75 East River Road, Minneapolis, MN, 55455
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Samuel D. Klein
Laurie L. Shekels
2Minneapolis Veterans Affairs Health Care System, 1 Veterans Dr, Minneapolis, MN 55417
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathryn A. McGuire
2Minneapolis Veterans Affairs Health Care System, 1 Veterans Dr, Minneapolis, MN 55417
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott R. Sponheim
2Minneapolis Veterans Affairs Health Care System, 1 Veterans Dr, Minneapolis, MN 55417
3University of Minnesota Department of Psychiatry and Behavioral Science, 606 24th Ave S, Minneapolis, MN 55454
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Scott R. Sponheim
  • For correspondence: sponh001{at}umn.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Impaired vigilance is a core cognitive deficit in schizophrenia and may serve as an endophenotype (i.e., mark genetic liability). We used a continuous performance task with perceptually degraded stimuli in schizophrenia patients (N=48), bipolar disorder patients (N=26), and first-degree biological relatives of schizophrenia patients (N=55) and bipolar disorder patients (N =28) and healthy controls (N=68) to clarify whether previously reported vigilance deficits and abnormal neural functions were indicative of genetic liability for schizophrenia as opposed to a generalized liability for severe psychopathology. We also examined variation in the Catechol-O-methyltransferase gene to evaluate whether brain responses were related to genetic variation associated with higher-order cognition. Relatives of schizophrenia patients had an increased rate of misidentification of nontarget stimuli as targets when they were perceptually similar, possibly reflecting difficulties with contour perception. Larger early visual responses (i.e., N1) were associated with better task performance, while reduced N2 augmentation to target stimuli was specific to schizophrenia patients. Both schizophrenia patients and relatives of schizophrenia patients displayed reduced late cognitive responses (P3b) that predicted worse performance. Bipolar patients and their relatives exhibited performance deficits and some aberrant neural responses that were milder and dependent on sex. Variation in the Catechol-O-methyltransferase gene was differentially associated with P3b in schizophrenia and bipolar groups. Poor vigilance in schizophrenia is specifically predicted by a failure to enhance early visual responses, weak augmentation of mid-latency brain responses to targets, and limited engagement of late cognitive responses that may be tied to genetic variation associated with prefrontal dopaminergic availability.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by grants from the Department of Veterans Affairs Clinical Science Research and Development Service (I01CX001843 to SRS), the National Institutes of Mental Health (R01MH112583 to SRS), and the Minnesota Medical Foundation (SMF-2075-99 to SRS); and by the Mental Health Patient Service Line at the Veterans Affairs Medical Center, Minneapolis Minnesota. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Department of Veterans Affairs or the Minnesota Medical Foundation. These funding sources played no role in study design, data collection, analysis, and interpretation, writing this report, or the decision to submit this article for publication.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • SRS developed hypotheses for the study. SDK designed figures and drafted the manuscript, with SRS providing critical feedback and substantially editing the manuscript. LLS and KAM reviewed and commented on the manuscript. KAM processed electrophysiological data. SDK, and SRS performed statistical analyses. LLS designed and oversaw the analysis of genetic specimens. All authors have seen and approve of the contents of the manuscript.

Data Availability

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted April 08, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Neural Anomalies during Vigilance in Schizophrenia: Diagnostic Specificity and Genetic Associations
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Neural Anomalies during Vigilance in Schizophrenia: Diagnostic Specificity and Genetic Associations
Samuel D. Klein, Laurie L. Shekels, Kathryn A. McGuire, Scott R. Sponheim
medRxiv 2020.04.03.20052100; doi: https://doi.org/10.1101/2020.04.03.20052100
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Neural Anomalies during Vigilance in Schizophrenia: Diagnostic Specificity and Genetic Associations
Samuel D. Klein, Laurie L. Shekels, Kathryn A. McGuire, Scott R. Sponheim
medRxiv 2020.04.03.20052100; doi: https://doi.org/10.1101/2020.04.03.20052100

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Psychiatry and Clinical Psychology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)